IRCT20161212031362N3
Investigation of safety and efficacy of intrathecal and intravenous injection of umbilical cord-derived mesenchymal stem cells
Investigation of safety and efficacy of intrathecal and intravenous injection of umbilical cord-derived mesenchymal stem cells (UC-MSC) in patients with multiple sclerosis
Tehran University of Medical Sciences·Phase 1·Iranian Registry Of Clinical Trial·drugCompleted
Study focus
- Disease/Condition
- Multiple sclerosis
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Tehran University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 1
- Start date
- Jan 20, 2023
- End date
- N/A
ICD-10 classifications
Multiple sclerosisProgressive systemic sclerosisSystemic sclerosisSystemic sclerosis, unspecifiedDiffuse sclerosis
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20161212031362N3
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20161212031362N3 through Pure Global AI's free database. This Phase 1 trial is sponsored by Tehran University of Medical Sciences and is currently Completed. The study focuses on Multiple sclerosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.